The antitumour activity of C21 steroidal glycosides and their derivatives of Baishouwu: A review

传统医学 糖苷 中医药 医学 化学 立体化学 病理 替代医学
作者
Xia Zhang,Ming Gao,Zhili Rao,Ziqin Lei,Jiuseng Zeng,Zhangjun Huang,Caihong Shen,Nan Zeng
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:293: 115300-115300 被引量:8
标识
DOI:10.1016/j.jep.2022.115300
摘要

Baishouwu has been used in China for thousands of years since it was first discovered in the late Tang Dynasty and flourished in the Song and Ming Dynasties. The Chinese herbal medicines named Baishouwu include Cynanchum auriculatum Royle ex Wight., Cynanchum bungei Decne. and Cynanchum wilfordii Hemsl. It is described in the Sign of Materia Medica as "sweet, bitter, reinforce liver and kidney, and non-toxic". It is widely used for nourishing the blood to expel wind, reinforcing liver and kidney, strengthening bones and muscles. In this review, the current research status of the C21 steroidal glycosides and their derivatives of Baishouwu for malignant tumours and their anti-tumour mechanisms are discussed. This may lay the ground for potential application of Baishouwu and its active ingredients in the treatment of tumours. Scientific databases, including PubMed, Elsevier, Science Direct, Google Scholar, CNKI, WANFANG DATA and VIP were searched to gather data about Baishouwu and its C21 steroidal glycosides and their derivatives. Prior literature indicates that Baishouwu has important biological activities such as anti-tumour, anti-epileptic, reducing cholesterol, protection of liver and kidney and immunomodulatory, which are of increasing interest, especially its anti-tumour activity. Recent studies demonstrate that the C21 steroidal glycosides of Baishouwu, which have prominent antitumour efficacy, are one of its main active ingredients. Presently, a variety of C21 steroidal glycosides have been isolated from Baishouwu medicinal part, the tuberous root. This review summarizes the various antitumour activities of the C21 steroidal glycosides and their derivatives of Baishouwu. In this review, the antitumour effects and mechanisms of total C21 steroidal glycosides and monomers and derivatives of Baishouwu in vitro and in vivo were summarized. Baishouwu can inhibit tumourigenesis by blocking tumour cell cycle progression, regulating numerous signaling pathways, promoting apoptosis, inhibiting tumour cells proliferation and metastasis, improving immunity and so on. This review provides a theoretical basis for inheriting and developing the medical heritage of the motherland, exploring the resources of traditional Chinese medicine for ethnic minorities and clinical rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男应助科研通管家采纳,获得10
刚刚
Rain完成签到 ,获得积分10
刚刚
牛角包完成签到,获得积分10
刚刚
Rare完成签到 ,获得积分10
刚刚
刚刚
Orange应助科研通管家采纳,获得10
刚刚
酷酷衣完成签到,获得积分20
1秒前
无花果应助bella采纳,获得10
1秒前
luz完成签到,获得积分10
1秒前
Cbbaby完成签到,获得积分10
2秒前
cola完成签到,获得积分10
2秒前
追寻紫安完成签到,获得积分10
3秒前
不仅要发文章还有发财完成签到,获得积分10
4秒前
4秒前
十七完成签到,获得积分10
5秒前
楠楠完成签到 ,获得积分10
5秒前
hah完成签到,获得积分10
5秒前
艾春完成签到 ,获得积分10
5秒前
6秒前
安静的十八完成签到,获得积分10
6秒前
小晴完成签到,获得积分10
6秒前
小千发布了新的文献求助10
6秒前
CipherSage应助研友_8DrX3n采纳,获得10
7秒前
传统的雁露完成签到,获得积分20
7秒前
急急急发布了新的文献求助10
8秒前
8秒前
8秒前
SciGPT应助TingWang采纳,获得10
8秒前
听风挽完成签到 ,获得积分10
9秒前
shuimenw完成签到,获得积分10
9秒前
孙文远完成签到,获得积分10
9秒前
慕容松完成签到,获得积分10
9秒前
王思祺完成签到,获得积分10
10秒前
粉色人ere123完成签到,获得积分20
10秒前
科研通AI2S应助柯亦云采纳,获得10
11秒前
666666神花露水完成签到 ,获得积分10
11秒前
singyu9发布了新的文献求助30
11秒前
11秒前
bjglp完成签到,获得积分10
12秒前
鹿璟璟完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951552
求助须知:如何正确求助?哪些是违规求助? 8635788
关于积分的说明 18311385
捐赠科研通 6394049
什么是DOI,文献DOI怎么找? 3082135
关于科研通互助平台的介绍 2127338
邀请新用户注册赠送积分活动 2059030